Tamarind Bio
YC W24 ↗San Francisco, US · Founded 2023 · Delaware corporation · 20 employees · 4 known investors
Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules. The platform integrates state-of-the-art published tools like AlphaFold and RFdiffusion through a user-friendly interface for life sciences companies.
AI & Machine LearningBiotechDeep TechEnterprise SoftwareSaaSAI-powered Drug DiscoveryArtificial IntelligenceB2Bin /tamarind-bio/@tamarindbioycombinator.com ↗
Founders & leadership· Y Combinator alumni (W24)
DK
Deniz Kaviin𝕏Co-founder & CEO
SL
Sherry LiuinFounder
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$13.6MraisedMay 2025 · 24 investors · Other TechnologyRule 506(b)
▶$13.6MraisedMay 2025 · 24 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- SHERRY LIUExecutive Officer, Director
- DENIZ KAVIExecutive Officer, Director
- Offering amount
- $13.6M
- Amount sold
- $13.6M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Tamarind Bio: startup de IA para fármacos levantó US$ 13.6M – El Ecosistema Startupecosistemastartup.com · 2026
- The Startup Building An Operating System For Biotech AIforbes.com · 2026
- Tamarind Bio Secures $13.6M Series A to Make AI More Accessible for Biologygenengnews.com · 2026
- Tamarind Bio: API for scalable bioinformaticsycombinator.com · 2024
- Tamarind Bio: No-code bioinformatics for scientistsycombinator.com · 2023
- Tamarind Bio Funding | Complete Analysis | Extruct AIextruct.ai
